| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.500 | None | 0.976 | 82 | 0 | 1979 | 2019 | ||||||||
|
glucose-6-phosphatase catalytic subunit | 0.560 | 0.692 | 1.8E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
glucose-6-phosphate dehydrogenase | 0.424 | 0.846 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1984 | 1984 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1986 | 1986 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1987 | 2003 | ||||||||
|
hemoglobin subunit alpha 2 | 0.512 | 0.808 | 3.1E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
hemoglobin subunit alpha 1 | 0.508 | 0.808 | 6.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1988 | 2018 | ||||||||
|
LIF interleukin 6 family cytokine | 0.483 | 0.769 | 0.52 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
hypoxanthine phosphoribosyltransferase 1 | 0.500 | 0.808 | 0.94 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
glucuronidase beta | 0.530 | 0.846 | 4.0E-08 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
arachidonate 12-lipoxygenase, 12S type | 0.558 | 0.692 | 1.4E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
calcitonin related polypeptide alpha | 0.416 | 0.923 | 1.6E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1995 | 2018 | ||||||||
|
thrombopoietin | 0.513 | 0.692 | 0.20 |
|
group | 0.180 | None | 1.000 | 8 | 0 | 1995 | 2020 | ||||||||
|
interleukin 3 | 0.489 | 0.731 | 2.6E-09 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2007 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2010 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2013 | ||||||||
|
MN1 proto-oncogene, transcriptional regulator | 0.682 | 0.385 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | |||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.200 | None | 0.988 | 173 | 0 | 1996 | 2020 | ||||||||
|
MPL proto-oncogene, thrombopoietin receptor | 0.510 | 0.692 | 4.1E-09 |
|
group | 0.500 | None | 1.000 | 89 | 3 | 1996 | 2020 | ||||||||
|
microsomal triglyceride transfer protein | 0.505 | 0.846 | 1.0E-05 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2009 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2015 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1996 | 2018 |